Potential Covid-19 vaccine from China shows positive results in human trials

A Covid-19 vaccine candidate developed by China National Biotec Group (CNBG) has shown positive results in early human trials. China National Biotec Group (CNBG) on Sunday,  June 28, said early human test results for its coronavirus vaccine candidate suggested it could be safe and effective. The experimental shot induced high-level antibodies in all inoculated participants in a Phase 1/2 clinical trial involving 1,120 healthy people. The trials were designed as randomised, double-blind and placebo-controlled studies. It is the second vaccine candidate from the firm to show positive results in a clinical trial.